CenterStar Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Sell
800
-1,800
-69% -$616K 0.05% 190
2026
Q1
$915K Buy
+2,600
New +$927K 0.11% 203
2025
Q2
Sell
-1,500
Closed -$467K 207
2025
Q1
$467K Buy
+1,500
New +$443K 0.11% 208
2023
Q4
Sell
-900
Closed -$242K 305
2023
Q3
$242K Buy
+900
New +$225K 0.05% 284
2021
Q2
Hold
0
-$95K 481
2021
Q1
Hold
0
520
2020
Q4
Hold
0
40
2020
Q3
Hold
0
95
2020
Q2
Hold
0
167
2020
Q1
Hold
0
159
2019
Q4
Hold
0
380
2019
Q3
Hold
0
96
2019
Q2
Hold
0
-$17K 350
2019
Q1
Hold
0
227
2018
Q4
Hold
0
334
2018
Q3
Hold
0
652
2018
Q2
Hold
0
266
2018
Q1
Hold
0
179

Other funds holding AMGN

CenterStar Asset Management's AMGN Position: Q2 2026 in Review

CenterStar Asset Management reduced its Amgen (AMGN) stake by 10% in Q2 2026, selling an estimated $30.8K and leaving 800 shares worth $290K. The position accounts for 0.05% of the portfolio, ranked #191.

CenterStar Asset Management first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $313K in Q1 2026. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • CenterStar Asset Management held 800 shares of Amgen worth $290K as of Q2 2026.
  • CenterStar Asset Management sold 90 Amgen shares in Q2 2026, an estimated $30.8K.
  • Amgen made up 0.05% of CenterStar Asset Management's portfolio in Q2 2026, its #191 holding.
  • CenterStar Asset Management first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • CenterStar Asset Management's Amgen position peaked at $313K in Q1 2026.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on CenterStar Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.